Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystalloid Coload Volumes on Norepinephrine ED90 for Postspinal Hypotension in Cesarean Section
NCT05690334Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Mar 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of norepinephrine and cold crystalloid solution in hypotension (3 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: 50% and 90% Effective Dose. Started Mar 2023; status: completed.
02
Drugs
norepinephrinecold crystalloid solution
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05690334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05690334.